This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Founded in 1846 and based in Ewing, NJ , Church & Dwight Co., Inc. develops, manufactures and markets a broad range of household, personal care and specialty products. It is the leading U.S. producer of sodium bicarbonate, popularly known as baking soda, a natural product that cleans, deodorized, leavens and buffers. The company operates in six countries (Canada, Mexico, U.K., France, Australia and Brazil) and exports to over 90 other countries. Approximately 17% of the company’s net sales came from outside the U.S. in 2019. The company has 12 key brands, including ARM & HAMMER, Trojan, OxiClean, Spinbrush, First Response, Nair, Orajel, Xtra, L’IL CRITTERS and VITAFUSION, Waterpik, FLAWLESS and Batiste. The company’s ARM & HAMMER brand is one of the nation’s most trusted trademarks for a broad range of consumer and specialty products and its products are sold under ARM & HAMMER liquid and powder laundry detergent, ARM & HAMMER cat litter, ARM & HAMMER dental care and ARM & HAMMER baking soda. Markedly, eleven out twelve power brands were acquired by the company and added to its portfolio since 2001.
Beat the Market the Zacks Way: Kazia Therapeutics, Uber, Medtronic in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Take the Zacks Approach to Beat the Market: Ulta Beauty, Clorox, Similarweb in Focus
by Abhinab Dasgupta
Last week, our time-tested methodologies served investors well in navigating the market. Check out some of our achievements from the past three months.
Church & Dwight (CHD) Q4 Earnings Top Estimates, Decline Y/Y
by Zacks Equity Research
Church & Dwight's (CHD) fourth-quarter 2022 results reflect improved sales and a decline in earnings per share. Soft consumption in discretionary categories is a downside.
Church & Dwight (CHD) Tops Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 3.33% and 2.91%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Q2 Earnings and Revenues Beat Estimates
by Zacks Equity Research
Clorox (CLX) delivered earnings and revenue surprises of 50.77% and 2.96%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
What's in Store for Church & Dwight (CHD) in Q4 Earnings?
by Zacks Equity Research
Church & Dwight's (CHD) Q4 earnings are likely to reflect gross margin contraction due to rising inflation. Nevertheless, it is resorting to incremental pricing actions to counter rising costs.
Colgate-Palmolive (CL) Matches Q4 Earnings Estimates
by Zacks Equity Research
Colgate-Palmolive (CL) delivered earnings and revenue surprises of 0% and 1.21%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Here's Why Colgate (CL) is Well-Poised for Earnings Beat in Q4
by Zacks Equity Research
Colgate's (CL) Q4 results are expected to reflect gains from strong consumer demand, innovation, brand strength, and focus on premiumization and digital transformation.
Church & Dwight (CHD) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release
by Zacks Equity Research
Church & Dwight (CHD) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Why Church & Dwight (CHD) is Poised to Beat Earnings Estimates Again
by Zacks Equity Research
Church & Dwight (CHD) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
Will Growth Efforts Aid Church & Dwight (CHD) Amid Inflation?
by Zacks Equity Research
Despite inflation concerns, Church & Dwight's (CHD) pricing efforts, buyouts and favorable demand act as upsides.
Constellation Brands (STZ) Q3 Earnings Lag Estimates
by Zacks Equity Research
Constellation Brands (STZ) delivered earnings and revenue surprises of -1.74% and 1.82%, respectively, for the quarter ended November 2022. Do the numbers hold clues to what lies ahead for the stock?
Clorox (CLX) Up 8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Clorox (CLX) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
5 Soaps & Cleaning Materials Stocks Showing Potential Amid Hardships
by Rajani Lohia
The soap and cleaning materials industry battles headwinds from elevated logistics, input and manufacturing costs. Innovation, digital growth and brand building are likely to drive players like PG, RBGLY, HENKY, CHD and CLX.
Church & Dwight (CHD) Q3 Earnings Beat Mark, Sales Rise Y/Y
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2022 results reflect increased sales on growth in Consumer Domestic and Specialty Products units. However, earnings decline year over year.
Church & Dwight (CHD) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Church & Dwight (CHD) delivered earnings and revenue surprises of 16.92% and 1.35%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Church & Dwight (CHD) Q3 Earnings Upcoming: Key Things to Note
by Zacks Equity Research
Church & Dwight's (CHD) third-quarter 2022 results are likely to reflect raw material cost inflation, high SG&A expenses and a slowdown in discretionary brands, while pricing actions are likely to have been an upside.
Sysco's (SYY) Recipe for Growth Bodes Well Amid High Costs
by Zacks Equity Research
Sysco (SYY) has been benefiting from its Recipe for Growth program and diversified business model amid high costs. In fiscal 2023, management expects inflation in the mid-single digits across all categories.
Implied Volatility Surging for Church & Dwight (CHD) Stock Options
by Zacks Equity Research
Investors need to pay close attention to Church & Dwight (CHD) stock based on the movements in the options market lately.
Top Analyst Reports for MSCI, Continental Resources & SVB Financial
by Sheraz Mian
Today's Research Daily features new research reports on 16 major stocks, including MSCI Inc. (MSCI), Continental Resources, Inc. (CLR) and SVB Financial Group (SIVB).
Brand Strength to Aid Colgate (CL) Despite High Inflation
by Zacks Equity Research
Despite rising raw material costs, Colgate's (CL) robust innovation and expansion plans are likely to drive growth in the long term.
Lamb Weston (LW) Benefits From Capacity Expansion, Pricing
by Zacks Equity Research
Lamb Weston (LW) has been gaining from its capacity-expansion endeavors, robust price/mix and Foodservice channel recovery amid escalated costs.
B&G Foods (BGS) Battles Cost Inflation, Banks on Pricing
by Zacks Equity Research
B&G Foods (BGS) has been battling cost inflation for a while now, which is likely to persist in 2022. Though pricing and favorable demand are upsides, inflation-related woes cannot be ignored.
Church & Dwight (CHD) Battles Cost Inflation, Banks on Demand
by Zacks Equity Research
Church & Dwight (CHD) has been battling cost inflation for a while now, which is likely to persist in 2022.Though pricing and favorable demand are upsides, inflation-related woes cannot be ignored.
Church & Dwight's (CHD) Buyout of Hero to Bolster Portfolio
by Zacks Equity Research
Church & Dwight (CHD) inks a deal to buy the Hero Mighty Patch brand (or Hero) and other acne treatment products. The deal is anticipated to close in the fourth quarter of 2022.